{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:15:59Z","timestamp":1794410159479,"version":"4.9.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Program of Zhejiang Respiratory Disease","award":["2025C02094"],"award-info":[{"award-number":["2025C02094"]}]},{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF22H160005"],"award-info":[{"award-number":["LGF22H160005"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13593-3","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T02:17:11Z","timestamp":1738635431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies"],"prefix":"10.1186","volume":"25","author":[{"given":"Jingjing","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinYan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"issue":"12","key":"13593_CR1","first-page":"3327","volume":"51","author":"I Kubonishi","year":"1991","unstructured":"Kubonishi I, Takehara N, Iwata J, Sonobe H, Ohtsuki Y, Abe T, Miyoshi I. Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma. Cancer Res. 1991;51(12):3327\u20138.","journal-title":"Cancer Res"},{"key":"13593_CR2","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-011811-132438","volume":"7","author":"CA French","year":"2012","unstructured":"French CA. Pathogenesis of NUT midline carcinoma. Annu Rev Pathol. 2012;7:247\u201365.","journal-title":"Annu Rev Pathol"},{"issue":"21","key":"13593_CR3","doi-asserted-by":"publisher","first-page":"E4184","DOI":"10.1073\/pnas.1702086114","volume":"114","author":"AA Alekseyenko","year":"2017","unstructured":"Alekseyenko AA, Walsh EM, Zee BM, Pakozdi T, Hsi P, Lemieux ME, Dal Cin P, Ince TA, Kharchenko PV, Kuroda MI, et al. Ectopic protein interactions within BRD4-chromatin complexes drive oncogenic megadomain formation in NUT midline carcinoma. Proc Natl Acad Sci U S A. 2017;114(21):E4184\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"13593_CR4","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1158\/2159-8290.CD-14-0014","volume":"4","author":"CA French","year":"2014","unstructured":"French CA, Rahman S, Walsh EM, Kuhnle S, Grayson AR, Lemieux ME, Grunfeld N, Rubin BP, Antonescu CR, Zhang S, et al. NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism. Cancer Discov. 2014;4(8):928\u201341.","journal-title":"Cancer Discov"},{"issue":"15","key":"13593_CR5","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","volume":"27","author":"CA French","year":"2008","unstructured":"French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, Kutok JL, Toretsky JA, Tadavarthy AK, Kees UR, et al. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene. 2008;27(15):2237\u201342.","journal-title":"Oncogene"},{"issue":"20","key":"13593_CR6","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1200\/JCO.2004.02.107","volume":"22","author":"CA French","year":"2004","unstructured":"French CA, Kutok JL, Faquin WC, Toretsky JA, Antonescu CR, Griffin CA, Nose V, Vargas SO, Moschovi M, Tzortzatou-Stathopoulou F, et al. Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol. 2004;22(20):4135\u20139.","journal-title":"J Clin Oncol"},{"key":"13593_CR7","doi-asserted-by":"publisher","first-page":"101640","DOI":"10.1016\/j.tranon.2023.101640","volume":"30","author":"J Chen","year":"2023","unstructured":"Chen J, Li M, Lu H. Nuclear protein in testis carcinoma of the lung. Transl Oncol. 2023;30:101640.","journal-title":"Transl Oncol"},{"issue":"2","key":"13593_CR8","doi-asserted-by":"publisher","first-page":"pkz094","DOI":"10.1093\/jncics\/pkz094","volume":"4","author":"NG Chau","year":"2020","unstructured":"Chau NG, Ma C, Danga K, Al-Sayegh H, Nardi V, Barrette R, Lathan CS, DuBois SG, Haddad RI, Shapiro GI, et al. An anatomical site and genetic-based prognostic model for patients with nuclear protein in Testis (NUT) Midline Carcinoma: analysis of 124 patients. JNCI Cancer Spectr. 2020;4(2):pkz094.","journal-title":"JNCI Cancer Spectr"},{"issue":"2","key":"13593_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12105-010-0174-6","volume":"4","author":"J Ziai","year":"2010","unstructured":"Ziai J, French CA, Zambrano E. NUT gene rearrangement in a poorly-differentiated carcinoma of the submandibular gland. Head Neck Pathol. 2010;4(2):163\u20138.","journal-title":"Head Neck Pathol"},{"issue":"6","key":"13593_CR10","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/JTO.0000000000000545","volume":"10","author":"LM Sholl","year":"2015","unstructured":"Sholl LM, Nishino M, Pokharel S, Mino-Kenudson M, French CA, Janne PA, Lathan C. Primary pulmonary NUT midline carcinoma: clinical, Radiographic, and Pathologic Characterizations. J Thorac Oncol. 2015;10(6):951\u20139.","journal-title":"J Thorac Oncol"},{"issue":"12","key":"13593_CR11","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1097\/PAS.0000000000001967","volume":"46","author":"JA Barletta","year":"2022","unstructured":"Barletta JA, Gilday SD, Afkhami M, Bell D, Bocklage T, Boisselier P, Chau NG, Cipriani NA, Costes-Martineau V, Ghossein RA, et al. NUTM1 -rearranged Carcinoma of the thyroid: a distinct subset of NUT Carcinoma characterized by frequent NSD3 - NUTM1 fusions. Am J Surg Pathol. 2022;46(12):1706\u201315.","journal-title":"Am J Surg Pathol"},{"key":"13593_CR12","doi-asserted-by":"publisher","first-page":"1091877","DOI":"10.3389\/fonc.2022.1091877","volume":"12","author":"H Jiang","year":"2022","unstructured":"Jiang H, Wang C, Hou Z, Wang Y, Qiao J, Li H. Case report: NUT carcinoma with MXI1::NUTM1 fusion characterized by abdominopelvic lesions and ovarian masses in a middle-aged female. Front Oncol. 2022;12:1091877.","journal-title":"Front Oncol"},{"key":"13593_CR13","doi-asserted-by":"publisher","first-page":"1094770","DOI":"10.3389\/fonc.2023.1094770","volume":"13","author":"S Fu","year":"2023","unstructured":"Fu S, Wang Z, Li C, Li Y, Zhang K, Zhong Z, Zhong Y. The whole treatment process and thinking of a patient with NUT carcinoma of the parotid gland: a case report. Front Oncol. 2023;13:1094770.","journal-title":"Front Oncol"},{"issue":"1","key":"13593_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/cncy.22342","volume":"129","author":"R Dutta","year":"2021","unstructured":"Dutta R, Nambirajan A, Mittal S, Roy-Chowdhuri S, Jain D. Cytomorphology of primary pulmonary NUT carcinoma in different cytology preparations. Cancer Cytopathol. 2021;129(1):53\u201361.","journal-title":"Cancer Cytopathol"},{"issue":"9","key":"13593_CR15","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1007\/s00432-023-04621-5","volume":"149","author":"M Chen","year":"2023","unstructured":"Chen M, Chen X, Zhang Y, Wang W, Jiang L. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case. J Cancer Res Clin Oncol. 2023;149(9):6361\u201370.","journal-title":"J Cancer Res Clin Oncol"},{"key":"13593_CR16","doi-asserted-by":"crossref","unstructured":"Martins B, Guimaraes S, Araujo D. Primary pulmonary NUT carcinoma: an aggressive and rare tumor. Arch Bronconeumol.2025;61(1):52\u201354.","DOI":"10.1016\/j.arbres.2024.09.012"},{"issue":"11","key":"13593_CR17","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1111\/1759-7714.13648","volume":"11","author":"YA Cho","year":"2020","unstructured":"Cho YA, Choi YL, Hwang I, Lee K, Cho JH, Han J. Clinicopathological characteristics of primary lung nuclear protein in testis carcinoma: a single-institute experience of 10 cases. Thorac Cancer. 2020;11(11):3205\u201312.","journal-title":"Thorac Cancer"},{"issue":"2","key":"13593_CR18","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S1470-2045(09)70286-4","volume":"11","author":"NJ Balamuth","year":"2010","unstructured":"Balamuth NJ, Womer RB. Ewing\u2019s sarcoma. Lancet Oncol. 2010;11(2):184\u201392.","journal-title":"Lancet Oncol"},{"key":"13593_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-pathol-011110-130237","volume":"7","author":"SL Lessnick","year":"2012","unstructured":"Lessnick SL, Ladanyi M. Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets. Annu Rev Pathol. 2012;7:145\u201359.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"13593_CR20","doi-asserted-by":"publisher","first-page":"2371575","DOI":"10.1080\/2162402X.2024.2371575","volume":"13","author":"J Qu","year":"2024","unstructured":"Qu J, Li Y, Wu B, Shen Q, Chen L, Sun W, Wang B, Ying L, Wu L, Zhou H, et al. CD161(+)CD127(+)CD8(+) T cell subsets can predict the efficacy of anti-PD-1 immunotherapy in non-small cell lung cancer with diabetes mellitus. Oncoimmunology. 2024;13(1):2371575.","journal-title":"Oncoimmunology"},{"issue":"12","key":"13593_CR21","doi-asserted-by":"publisher","first-page":"E1045","DOI":"10.21037\/jtd.2017.11.50","volume":"9","author":"J Cao","year":"2017","unstructured":"Cao J, Chen D, Yang F, Yao J, Zhu W, Zhao C. NUT midline carcinoma as a primary lung tumor: a case report. J Thorac Dis. 2017;9(12):E1045\u20139.","journal-title":"J Thorac Dis"},{"issue":"17","key":"13593_CR22","doi-asserted-by":"publisher","first-page":"5757","DOI":"10.1002\/cam4.4096","volume":"10","author":"M Xie","year":"2021","unstructured":"Xie M, Fu X, Wang W. Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma. Cancer Med. 2021;10(17):5757\u201364.","journal-title":"Cancer Med"},{"issue":"6","key":"13593_CR23","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/his.14306","volume":"78","author":"YP Hung","year":"2021","unstructured":"Hung YP, Chen AL, Taylor MS, Huynh TG, Kem M, Selig MK, Nielsen GP, Lennerz JK, Azzoli CG, Dagogo-Jack I, et al. Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor-1 and neuroendocrine markers. Histopathology. 2021;78(6):896\u2013904.","journal-title":"Histopathology"},{"issue":"3","key":"13593_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4103\/jcrt.jcrt_1887_20","volume":"19","author":"S Pasricha","year":"2023","unstructured":"Pasricha S, Jajodia A, Sharma A, Bansal D, Batra U, Gupta G, Durga G, Kamboj M, Nathany S, Mehta A. Primary pulmonary NUT midline carcinoma: an elusive and a rare diagnostic entity. J Cancer Res Ther. 2023;19(3):816\u20138.","journal-title":"J Cancer Res Ther"},{"issue":"1","key":"13593_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13000-021-01188-y","volume":"17","author":"J Jiang","year":"2022","unstructured":"Jiang J, Ren Y, Xu C, Lin X. NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report. Diagn Pathol. 2022;17(1):4.","journal-title":"Diagn Pathol"},{"key":"13593_CR26","doi-asserted-by":"publisher","first-page":"108015","DOI":"10.1016\/j.ijscr.2023.108015","volume":"105","author":"NJ Alcasid","year":"2023","unstructured":"Alcasid NJ, Banks KC, Sun A, Velotta JB. Case report on the role of aggressive palliative surgery in lung NUT carcinoma after induction chemoimmunotherapy. Int J Surg Case Rep. 2023;105:108015.","journal-title":"Int J Surg Case Rep"},{"key":"13593_CR27","doi-asserted-by":"publisher","first-page":"1083206","DOI":"10.3389\/fmed.2022.1083206","volume":"9","author":"W Huang","year":"2023","unstructured":"Huang W, Zhang Y, Yang Q, Gao G, Qiu Y, Li L, Kang L. Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma. Front Med (Lausanne). 2023;9:1083206.","journal-title":"Front Med (Lausanne)"},{"key":"13593_CR28","doi-asserted-by":"publisher","first-page":"890338","DOI":"10.3389\/fonc.2022.890338","volume":"12","author":"R Zhao","year":"2022","unstructured":"Zhao R, Hua Z, Hu X, Zhang Q, Zhang J, Wang J. NUT carcinoma of the lung: a Case report and literature analysis. Front Oncol. 2022;12:890338.","journal-title":"Front Oncol"},{"issue":"9","key":"13593_CR29","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1093\/oncolo\/oyad177","volume":"28","author":"HG Kaplan","year":"2023","unstructured":"Kaplan HG, Subramaniam S, Vallieres E, Barnett T. Prolonged survival of NUT Midline Carcinoma and current approaches to treatment. Oncologist. 2023;28(9):765\u201370.","journal-title":"Oncologist"},{"issue":"7","key":"13593_CR30","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1097\/PAS.0b013e318198d666","volume":"33","author":"H Haack","year":"2009","unstructured":"Haack H, Johnson LA, Fry CJ, Crosby K, Polakiewicz RD, Stelow EB, Hong SM, Schwartz BE, Cameron MJ, Rubin MA, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. 2009;33(7):984\u201391.","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"13593_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jtho.2023.12.022","volume":"19","author":"J Luo","year":"2024","unstructured":"Luo J, Sanchez M, Lee E, Hertzler H, Luong N, Mazzola E, Finstein B, Tamen R, Brisbane G, Nguyen T, et al. Initial chemotherapy for locally Advanced and metastatic NUT carcinoma. J Thorac Oncol. 2024;19(5):829\u201338.","journal-title":"J Thorac Oncol"},{"key":"13593_CR32","doi-asserted-by":"publisher","first-page":"107496","DOI":"10.1016\/j.lungcan.2024.107496","volume":"189","author":"LD Kloker","year":"2024","unstructured":"Kloker LD, Sidiras M, Flaadt T, Brecht IB, Deinzer CKW, Gross T, Benzler K, Zender L, Lauer UM. Clinical management of NUT carcinoma (NC) in Germany: analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients. Lung Cancer. 2024;189:107496.","journal-title":"Lung Cancer"},{"key":"13593_CR33","doi-asserted-by":"publisher","first-page":"690115","DOI":"10.3389\/fonc.2021.690115","volume":"11","author":"X Li","year":"2021","unstructured":"Li X, Shi H, Zhang W, Bai C, He M, Ta N, Huang H, Ning Y, Fang C, Qin H, et al. Immunotherapy and Targeting the Tumor Microenvironment: current place and New insights in primary pulmonary NUT carcinoma. Front Oncol. 2021;11:690115.","journal-title":"Front Oncol"},{"issue":"1","key":"13593_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1158\/2159-8290.CD-17-0605","volume":"8","author":"A Stathis","year":"2018","unstructured":"Stathis A, Bertoni F. BET Proteins as targets for Anticancer Treatment. Cancer Discov. 2018;8(1):24\u201336.","journal-title":"Cancer Discov"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13593-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13593-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13593-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T02:17:18Z","timestamp":1738635438000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13593-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13593"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13593-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4236640\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of the First Affiliated Hospital, Zhejiang University School of Medicine. The informed consent waiver was supported by the Institutional Review Board of the First Affiliated Hospital, Zhejiang University School of Medicine (Approved No:2024\u2009\u2212\u20090387).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}